InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
4
T+90 hit rate
0%
T+90 mean return
-63.4%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Miller Steve, Chief Operating Officer. Director active across 1 company, notably Catalyst Pharmaceuticals, INC.. Cumulatively, 24 disclosures have been published. Breakdown: 1 buy · 4 sells. Total volume traded: €3m. Activity tracked since 13 August 2021. The latest transaction was disclosed on 15 July 2026 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Miller Steve
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations24 total
1,093,803 shares@ US$31.500.89% mcap85.3% of flowCommon Stock, par value $0.001 per shareSEC:0001161697-26-000180:0
14,000 sharesCommon stock, par value $0.001 per shareSEC:0001161697-25-000494:0
11,873 sharesCommon stock, par value $0.001 per shareSEC:0001161697-25-000448:0
8,267 sharesCommon stock, par value $0.001 per shareSEC:0001161697-25-000420:0
115,000 shares@ US$2.244.3% of flowCommon stock, par value $0.001 per shareSEC:0001161697-25-000301:0
13,667 sharesCommon stock, par value $0.001 per shareSEC:0001161697-25-000070:0
14,000 sharesCommon stock, par value $0.001 per shareSEC:0001161697-24-000542:0
235,000 shares@ US$4.0116.5% of flowCommon stock, par value $0.001 per shareSEC:0001161697-24-000523:0
11,872 sharesCommon stock, par value $0.001 per shareSEC:0001161697-24-000505:0
50,000 shares@ US$20.26116.7% of flowCommon stock, par value $0.001 per shareSEC:0001161697-24-000367:0
13,667 sharesCommon stock, par value $0.001 per shareSEC:0001161697-24-000103:0
14,000 sharesCommon stock, par value $0.001 per shareSEC:0001161697-23-000650:0
150,000 shares@ US$1.132.9% of flowCommon stock, par value $0.001 per shareSEC:0001161697-23-000621:0
40,000 shares@ US$14.249.6% of flowCommon stock, par value $0.001 per shareSEC:0001161697-23-000586:0
100,000 shares@ US$0.791.3% of flowCommon stock, par value $0.001 per shareSEC:0001161697-23-000286:0
13,666 sharesCommon stock, par value $0.001 per shareSEC:0001161697-23-000132:0
20,000 sharesCommon stock, par value $0.001 per shareSEC:0001161697-22-000576:0
80,000 shares@ US$15.27621.7% of flowCommon stock, par value $0.001 per shareSEC:0001161697-22-000561:0
25,000 shares@ US$17.0077.8% of flowCommon stock, par value $0.001 per shareSEC:0001161697-22-000456:0
118,575 shares@ US$2.535.5% of flowCommon stock, par value $0.001 per shareSEC:0001161697-22-000400:0
20,000 sharesCommon stock, par value $0.001 per shareSEC:0001161697-21-000559:0
120,000 shares@ US$3.120.9% of flowCommon stock, par value $0.001 per shareSEC:0001161697-21-000410:0
65,000 shares@ US$3.120.5% of flowCommon stock, par value $0.001 per shareSEC:0001161697-21-000385:0
7,933 sharesCommon stock, par value $0.001 per shareSEC:0001161697-16-000618:0
Canonical exit: 10 Apr 2016 (T+90)
24 of 24 declarations
About Miller Steve
Miller Steve is Director of Operations and Chief Op. & Scientific Officer at Catalyst Pharmaceuticals, INC. He has 24 filings in total, and across the sampled recent filings from 2016-01-12 to 2026-07-17, the reported volume is EUR 0 on the buy side and EUR 33165195 on the sell side, with Levée d'options as the most frequent transaction nature.
